The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice

Transplant Immunology

Volumn 20, Issue 4, 2009, Pages 253-260

  Javeed, Aqeel ^a,b   Zhang, Baojun ^a,b   Qu, Yanyan ^a,b   Zhang, Aijun ^a,b   Sun, Chenming ^a,b   Zhang, Lianjun ^a,b   Liu, Jun ^a,b   Zeng, Chun ^a,b   Zhao, Yong ^a,b  

^a INSTITUTE OF ZOOLOGY   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Aspirin; Autoimmune diseases; Immune tolerance; Regulatory T cells

Indexed keywords

ACETYLSALICYLIC ACID; CD45RB ANTIGEN; CD69 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; HERMES ANTIGEN; L SELECTIN; TRANSCRIPTION FACTOR FOXP3;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; BAGG ALBINO MOUSE; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG MEGADOSE; EFFECTOR CELL; FEMALE; GRAFT REJECTION; HOST SUSCEPTIBILITY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; LOW DRUG DOSE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; THERAPY EFFECT; THYMOCYTE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANIMALS; ASPIRIN; CELL PROLIFERATION; CELL SEPARATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; IMMUNOPHENOTYPING; IMMUNOSUPPRESSION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND;

EID: 59649093112     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2008.12.001     Document Type: Article

References (54)

1. O'Garra A., and Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med 10 8 (2004) 801
2. + regulatory T cells. Nat Immunol 4 4 (2003) 330
3. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 5609 (2003) 1057
4. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 162 9 (1999) 5317
5. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 182 (2001) 18
6. + suppressor T cells: more questions than answers. Nat Rev Immunol 2 6 (2002) 389
7. Jonuleit H., Schmitt E., Stassen M., Tuettenberg A., Knop J., and Enk A.H. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 193 11 (2001) 1285
8. Ng W.F., Duggan P.J., Ponchel F., Matarese G., Lombardi G., Edwards A.D., et al. Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood 98 9 (2001) 2736
9. Zhang L., and Zhao Y. The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road. J Cell Physiol 211 3 (2007) 590
10. Green E.A., Choi Y., and Flavell R.A. Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity 16 2 (2002) 183
11. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12 4 (2000) 431
12. + regulatory T cells exacerbates sodium iodide-induced experimental autoimmune thyroiditis in human leucocyte antigen DR3 (DRB1*0301) transgenic class II-knock-out non-obese diabetic mice. Clin Exp Immunol 147 3 (2007) 547
13. Maloy K.J., and Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2 9 (2001) 816
14. Miyara M., Amoura Z., Parizot C., Badoual C., Dorgham K., Trad S., et al. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 175 12 (2005) 8392
15. Graca L., Thompson S., Lin C.Y., Adams E., Cobbold S.P., and Waldmann H. Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance. J Immunol 168 11 (2002) 5558
16. + regulatory T cells contributes to skin transplant tolerance. Transplantation 76 9 (2003) 1375
17. + T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome. Transplantation 77 5 (2004) 762
18. + regulatory T cells: evidence for in vivo inhibition of effector cell proliferation. J Immunol 172 11 (2004) 6539
19. - T cells by in vitro Foxp3 gene transfer, can induce transplantation tolerance. Transplantation 79 10 (2005) 1310
20. Hara M., Kingsley C.I., Niimi M., Read S., Turvey S.E., Bushell A.R., et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 166 6 (2001) 3789
21. + regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol 168 3 (2002) 1080
22. Flower R. What are all the things that aspirin does?. Bmj 327 7415 (2003) 572
23. McAdam B.F., Catella-Lawson F., Mardini I.A., Kapoor S., Lawson J.A., and FitzGerald G.A. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci U S A 96 1 (1999) 272
24. Vane J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231 25 (1971) 232
25. van Walraven C., Hart R.G., Singer D.E., Laupacis A., Connolly S., Petersen P., et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. Jama 288 19 (2002) 2441
26. Weisman S.M., and Graham D.Y. Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. Arch Intern Med 162 19 (2002) 2197
27. Mangano D.T. Aspirin and mortality from coronary bypass surgery. N Engl J Med 347 17 (2002) 1309
28. Caughey G.E., Cleland L.G., Penglis P.S., Gamble J.R., and James M.J. Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2. J Immunol 167 5 (2001) 2831
29. Grotz W., Siebig S., Olschewski M., Strey C.W., and Peter K. Low-dose aspirin therapy is associated with improved allograft function and prolonged allograft survival after kidney transplantation. Transplantation 77 12 (2004) 1848
30. Ariel A., Chiang N., Arita M., Petasis N.A., and Serhan C.N. Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells. J Immunol 170 12 (2003) 6266
31. Cianferoni A., Schroeder J.T., Kim J., Schmidt J.W., Lichtenstein L.M., Georas S.N., et al. Selective inhibition of interleukin-4 gene expression in human T cells by aspirin. Blood 97 6 (2001) 1742
32. Viñals M., Bermúdez I., Llaverias G., Alegret M., Sanchez R.M., Vázquez-Carrera M., et al. Aspirin increases CD36, SR-BI, and ABCA1 expression in human THP-1 macrophages. Cardiovasc Res 66 1 (2005) 141
33. Tancevski I., Wehinger A., Schgoer W., Eller P., Cuzzocrea S., Foeger B., et al. Aspirin regulates expression and function of scavenger receptor-BI in macrophages: studies in primary human macrophages and in mice. Faseb J 20 9 (2006) 1328
34. Wang H., Zhao L., Sun Z., Sun L., Zhang B., and Zhao Y. A potential side effect of cyclosporin A: inhibition of CD4(+)CD25(+) regulatory T cells in mice. Transplantation 82 11 (2006) 1484
35. +T cells in xenogeneic neonatal porcine thymus-grafted athymic mice. Am J Transplant 6 12 (2006) 2841
36. + regulatory T cells in aged Balb/c mice. J Leukoc Biol 81 6 (2007) 1386
37. + T cells. Cell Mol Immunol 3 3 (2006) 189
38. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155 3 (1995) 1151
39. + regulatory cells. J Thorac Cardiovasc Surg 130 4 (2005) 1167
40. Kopp E., and Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265 5174 (1994) 956
41. + T cells. J Immunol 175 3 (2005) 1483
42. + adaptive regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin E2-dependent mechanism. J Immunol 177 1 (2006) 246
43. + T regulatory cell activities in lung cancer. Cancer Res 65 12 (2005) 5211
44. Shiff S.J., Qiao L., Tsai L.L., and Rigas B. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J Clin Invest 96 1 (1995) 491
45. Piazza G.A., Rahm A.K., Finn T.S., Fryer B.H., Li H., Stoumen A.L., et al. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction. Cancer Res 57 12 (1997) 2452
46. Bellosillo B., Piqué M., Barragán M., Castaño E., Villamor N., Colomer D., et al. Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells. Blood 92 4 (1998) 1406
47. Dikshit P., Chatterjee M., Goswami A., Mishra A., and Jana N.R. Aspirin induces apoptosis through the inhibition of proteasome function. J Biol Chem 281 39 (2006) 29228
48. Matasic R., Dietz A.B., and Vuk-Pavlovic S. Cyclooxygenase-independent inhibition of dendritic cell maturation by aspirin. Immunology 101 1 (2000) 53
49. Hackstein H., Morelli A.E., Larregina A.T., Ganster R.W., Papworth G.D., Logar A.J., et al. Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells. J Immunol 166 12 (2001) 7053
50. Yin M.J., Yamamoto Y., and Gaynor R.B. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396 6706 (1998) 77
51. Buckland M., Jago C.B., Fazekasova H., et al. Aspirin-treated human DCs up-regulate ILT-3 and induce hyporesponsiveness and regulatory activity in responder T cells. Am J Transplant 6 9 (2006) 2046
52. Fritzsching B., Oberle N., Pauly E., Geffers R., Buer J., Poschl J., et al. Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death. Blood 108 10 (2006) 3371
53. - T cells to dexamethasone-induced cell death. Eur J Immunol 34 3 (2004) 859
54. + regulatory T cells in mice: potential implication for the treatment of autoimmune diseases. J Mol Med 85 11 (2007) 1263